Found: 33
Select item for more details and to access through your institution.
Long-term Outcomes and Prognosis in New-Onset Psoriasis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review.
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 309, doi. 10.2147/PPA.S238843
- By:
- Publication type:
- Article
Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis.
- Published in:
- Patient Preference & Adherence, 2017, p. 719, doi. 10.2147/PPA.S128665
- By:
- Publication type:
- Article
Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line.
- Published in:
- Patient Preference & Adherence, 2017, v. 11, p. 95, doi. 10.2147/PPA.S119808
- By:
- Publication type:
- Article
Serum beta-defensin-2 is a biomarker for psoriasis but not subclinical atherosclerosis: Role of IL17a, PI-3 kinase and Rac1.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 1, p. 150, doi. 10.1002/jvc2.278
- By:
- Publication type:
- Article
Sick leave and disability pension before and after diagnosis of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 14, p. 1859, doi. 10.1177/1352458516667567
- By:
- Publication type:
- Article
Reversal in the secular trend of hip fracture incidences in Austria.
- Published in:
- 2010
- By:
- Publication type:
- Letter
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recovery of quality of life is associated with lower mortality 5-year post-fracture: the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS).
- Published in:
- Archives of Osteoporosis, 2021, v. 16, n. 1, p. 1, doi. 10.1007/s11657-021-00981-y
- By:
- Publication type:
- Article
Quality of life after fragility fracture in the Russian Federation: results from the Russian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (ICUROS).
- Published in:
- Archives of Osteoporosis, 2020, v. 15, n. 1, p. 1, doi. 10.1007/s11657-020-0699-6
- By:
- Publication type:
- Article
Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.7312
- By:
- Publication type:
- Article
Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: A Register Study.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.7138
- By:
- Publication type:
- Article
The Impact of Systemic Treatment of Atopic Dermatitis on Depressive Symptoms: A Prospective Clinical Cohort Study.
- Published in:
- Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.803
- By:
- Publication type:
- Article
Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register Analysis.
- Published in:
- Acta Dermato-Venereologica, 2016, v. 96, n. 5, p. 651, doi. 10.2340/00015555-2329
- By:
- Publication type:
- Article
Increased Cause-specific Mortality in Patients with Mild and Severe Psoriasis: A Population-based Swedish Register Study.
- Published in:
- Acta Dermato-Venereologica, 2015, v. 95, n. 7, p. 809, doi. 10.2340/00015555-2095
- By:
- Publication type:
- Article
Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort Study.
- Published in:
- Clinical Epidemiology, 2024, v. 16, p. 213, doi. 10.2147/CLEP.S454677
- By:
- Publication type:
- Article
The long-term impact of early treatment of multiple sclerosis on the risk of disability pension.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 3, p. 701, doi. 10.1007/s00415-018-8764-4
- By:
- Publication type:
- Article
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e240407, doi. 10.1001/jamanetworkopen.2024.0407
- By:
- Publication type:
- Article
Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France—results from the ICUROS study.
- Published in:
- Osteoporosis International, 2022, v. 33, n. 3, p. 625, doi. 10.1007/s00198-021-06189-7
- By:
- Publication type:
- Article
Thirty years of hip fracture incidence in Austria: is the worst over?
- Published in:
- Osteoporosis International, 2022, v. 33, n. 1, p. 97, doi. 10.1007/s00198-021-06086-z
- By:
- Publication type:
- Article
Second-line treatment persistence and costs among patients with immune-mediated rheumatic diseases treated with subcutaneous TNF-alpha inhibitors.
- Published in:
- Rheumatology International, 2017, v. 37, n. 12, p. 2049, doi. 10.1007/s00296-017-3825-z
- By:
- Publication type:
- Article
An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 4, p. 1199, doi. 10.1007/s11136-022-03303-y
- By:
- Publication type:
- Article
Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Health Service Use and Quality of Life Recovery 12 Months Following Major Osteoporotic Fracture: Latent Class Analyses of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
- Published in:
- Journal of Bone & Mineral Research, 2021, v. 36, n. 2, p. 252, doi. 10.1002/jbmr.4181
- By:
- Publication type:
- Article
The Osteoporosis Treatment Gap.
- Published in:
- 2014
- By:
- Publication type:
- Other
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 10, p. 4657, doi. 10.1007/s12325-023-02600-3
- By:
- Publication type:
- Article
Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2468, doi. 10.1007/s12325-021-01970-w
- By:
- Publication type:
- Article
Correction to: Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 244, doi. 10.1007/s12325-021-01879-4
- By:
- Publication type:
- Article
Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 9, p. 3746, doi. 10.1007/s12325-020-01425-8
- By:
- Publication type:
- Article
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence.
- Published in:
- Rheumatology International, 2016, v. 36, n. 7, p. 987, doi. 10.1007/s00296-016-3423-5
- By:
- Publication type:
- Article
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain.
- Published in:
- ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 747, doi. 10.2147/CEOR.S167727
- By:
- Publication type:
- Article